Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.9K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

medRxiv : the preprint server for health sciences·2026
Same author

Improvement in Health-Related Quality of Life in Patients with Moderate to Severe Crohn's Disease Treated with Risankizumab vs Ustekinumab in the Phase 3B SEQUENCE Study.

The American journal of gastroenterology·2026
Same author

Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trial.

Nature communications·2026
Same author

Efficacy and safety of ABBV-154 in patients with moderately to severely active Crohn's disease: a phase 2b, randomized, double-blind, placebo-controlled trial.

Crohn's & colitis 360·2026
Same author

Effects of prehabilitation programmes on postoperative outcomes in older adults undergoing major abdominal, cardiac or vascular surgery: a systematic review.

Aging clinical and experimental research·2026
Same journal

Trembling technique for improving colonic adenoma detection rate by enhancing mucosal exposure during withdrawal: A prospective, non-randomized single center study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Consensus recommendations for the management of H. pylori in Egypt: 2026 report.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Can we predict the high-risk patient?

Jose-Manuel Benitez1, Edouard Louis

  • 1Department of Gastroenterology, CHU Liège, and GIGA Research, Liège University, Liège, Belgium.

Digestive Diseases (Basel, Switzerland)
|June 28, 2014
PubMed
Summary
This summary is machine-generated.

Predicting aggressive inflammatory bowel diseases (IBD) requires clinical, biological, and endoscopic tools. While helpful, these methods for forecasting IBD evolution need further validation with new markers.

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

788

Related Experiment Videos

Last Updated: Apr 27, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

788

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Clinical Research

Background:

  • Therapeutic strategies for inflammatory bowel diseases (IBD) are evolving.
  • Identifying factors for aggressive disease is crucial for personalized treatment decisions.
  • Risk-benefit assessment necessitates reliable predictors of disease progression.

Purpose of the Study:

  • To review tools for predicting IBD disease evolution in clinical practice.
  • To identify current methods assisting clinicians in managing IBD.
  • To highlight the need for improved predictive markers in IBD management.

Main Methods:

  • Literature review utilizing PubMed database.
  • Search terms included IBD, Crohn's disease, ulcerative colitis, genetics, biomarkers, endoscopy, and disease evolution.
  • Focus on tools applicable in routine clinical practice.

Main Results:

  • Clinical characteristics like disease location and behavior are primary predictors of IBD evolution.
  • Biomarkers (genetic, serological, inflammatory) and endoscopic findings offer potential added value.
  • Current tools provide some predictive capability for disease course.

Conclusions:

  • Simple clinical, biological, and endoscopic assessments aid in predicting IBD progression.
  • Existing tools are currently insufficient for precise prediction.
  • Prospective evaluation of novel genetic and biological markers is essential for advancing IBD management.